We are live on ! Find out more
DFTX

Definium Therapeutics
DFTX

159 hedge funds and large institutions have $53.6M invested in Definium Therapeutics in 2022 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 33 increasing their positions, 41 reducing their positions, and 48 closing their positions.

New
Increased
Maintained
Reduced
Closed

180% more call options, than puts

Call options by funds: $4.31M | Put options by funds: $1.54M

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.06% less ownership

Funds ownership: 0.82% → 0.76% (-0.06%)

10% less funds holding

Funds holding: 176 → 159 (-17)

20% less repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 41

26% less capital invested

Capital invested by funds: $72.4M → $53.6M (-$18.9M)

33% less first-time investments, than exits

New positions opened: 32 | Existing positions closed: 48

Holders
159
Holders Change
-17
Holders Change %
-9.66%
% of All Funds
2.51%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
32
Increased
33
Reduced
41
Closed
48
Calls
$4.31M
Puts
$1.54M
Net Calls
+$2.77M
Net Calls Change
-$81K

Top Buyers

1
State Street
State Street
Massachusetts
+$482K
2
MI
MMCAP International
Cayman Islands
+$278K
3
PCM
Penserra Capital Management
California
+$276K
4
AI
AdvisorShares Investments
Maryland
+$268K
5
Swiss National Bank
Swiss National Bank
Switzerland
+$206K

Top Sellers

1
Millennium Management
Millennium Management
New York
-$740K
2
BlackRock
BlackRock
New York
-$730K
3
LPL Financial
LPL Financial
California
-$534K
4
Citadel Advisors
Citadel Advisors
Florida
-$533K
5
Two Sigma Investments
Two Sigma Investments
New York
-$516K
Name Holding Trade Value Shares
Change 		Change in
Stake
Principal Financial Group
51
Principal Financial Group
Iowa
$65K -$815 -47 -1%
Creative Planning
52
Creative Planning
Kansas
$62K -$2.98K -172 -4%
Two Sigma Advisers
53
Two Sigma Advisers
New York
$58K -$5.08K -293 -8%
Barclays
54
Barclays
United Kingdom
$58K +$60.5K +3,485 New
Stifel Financial
55
Stifel Financial
Missouri
$56K +$4.04K +233 +8%
State Board of Administration of Florida Retirement System
56
State Board of Administration of Florida Retirement System
Florida
$53K – – –
AB
57
Amalgamated Bank
New York
$53K +$55.4K +3,196 New
Bank of America
58
Bank of America
North Carolina
$52K -$125K -7,200 -69%
Toronto Dominion Bank
59
Toronto Dominion Bank
Ontario, Canada
$52K +$5.33K +307 +11%
HSBC Holdings
60
HSBC Holdings
United Kingdom
$48K +$5.6K +323 +13%
SAM
61
Shell Asset Management
Netherlands
$43K – – –
AWM
62
Accurate Wealth Management
Florida
$38K +$39.7K +2,289 New
National Bank of Canada
63
National Bank of Canada
Quebec, Canada
$37K -$166K -9,570 -81%
SWP
64
Stratos Wealth Partners
Ohio
$37K – – –
CG
65
Cutler Group
California
$37K +$4.04K +233 +12%
APA
66
American Portfolios Advisors
New York
$33.3K – – –
HNB
67
Huntington National Bank
Ohio
$33K – – –
T. Rowe Price Associates
68
T. Rowe Price Associates
Maryland
$33K +$7.53K +434 +28%
PAMS
69
Pictet Asset Management (Switzerland)
Switzerland
$30K – – –
VF
70
Virtu Financial
New York
$29K +$30.1K +1,736 New
PPA
71
Parametric Portfolio Associates
Washington
$28K -$218K -12,586 -88%
AIP
72
Ameritas Investment Partners
Nebraska
$28K – – –
UBS Group
73
UBS Group
Switzerland
$24K -$98.9K -5,700 -80%
KJHP
74
K.J. Harrison & Partners
Ontario, Canada
$24K – – –
Nisa Investment Advisors
75
Nisa Investment Advisors
Missouri
$24K +$25.4K +1,463 New
1 2
3
4 5

DFTX Hedge Fund Activity: Q1 2022 in Review

159 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Definium Therapeutics (DFTX) for Q1 2022, worth a combined $53.6M — down 26% from $72.4M a quarter earlier.

Sellers outnumbered buyers: 48 funds closed out of DFTX and 32 opened new positions — a net loss of 16 holders — while 41 trimmed existing stakes and 33 added.

The largest buyer was State Street, adding an estimated $482K. The largest seller was Millennium Management, cutting an estimated $740K.

  • 159 institutional investors held Definium Therapeutics (DFTX) as of Q1 2022, down from 176 in Q4 2021.
  • Funds reported $53.6M of Definium Therapeutics stock for Q1 2022, down 26% quarter-over-quarter.
  • 32 funds opened new Definium Therapeutics positions in Q1 2022 and 48 closed out, a net change of -16 holders.
  • The largest Definium Therapeutics buyer in Q1 2022 was State Street, an estimated $482K added.
  • The largest Definium Therapeutics seller in Q1 2022 was Millennium Management, an estimated $740K sold.

Based on aggregated 13F filings for Q1 2022.